MS Views and News Be empowered with MS views and news. CLICK HERE - - to SUBSCRIBE for The MS BEACON e-Newsletter

MS Views and News uses state-of-the-art technology to provide resources to the MS Community. Visit our MS learning channel on YouTube, to gain knowledge from hundreds of MS educational videos presented by MS Experts from across the USA. Click:

Within this blog you can find MS resources by viewing all showing below pertaining to thousands of MS articles, resources, event timing. Additionally, please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for those affected by Multiple Sclerosis. * From the comfort of your home, you can join us for our VIRTUAL MS events. To learn more of these virtual events please subscribe here.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Saturday, October 3, 2015

Help MS Views and News by SHOPPING ONLINE

MS Views and News offers educational programs to our ms community at no charge to the patient or their caregivers. Now there is a way that you can donate to this organization every time you shop! 

Simply register on the website:
Use your own email address
Create a password

Purchase your everyday products by merely transferring your shopping list to our web portal. On the site, you will find 3500 partner stores such as Walmart, Sears, Target & Macy's along with many others. Simply log into and enter your email address and begin shopping. You will be taken directly to that store and can take advantage of their sales, use coupons & get paid to shop, while a donation is being made to MS Views & News.

As a thank you for shopping online, all members will receive CASHBACK in the amount of 2-50% of your spending. The company tracks your purchases and every time you sign in, t will display your total of CASHBACK. You can request a check or spend the money in any store next time you log in. and Market America also have exclusive branded products such as laundry soap, shampoo, conditioner, body soap, multi vitamins & vitamin D along with 2000 other products. By ordering these products, MS Views & News will receive royalty checks per month that will help support the amazing events that many of you have attended. As a non-profit, MS Views & Views counts on outside donations to fund these events. Now you, too, can help!

Over 2000 non profit organizations around the country are participating in this program. There is no obligation, no minimums and no charges to either you, the consumer, or to MS Views & News. Other organizations such as churches, schools, temples and pet rescues are benefiting from their members shopping online and purchasing our exclusive branded products!

You can register at and immediately go shopping. If you help us capture other shoppers, you will also receive 1/2%.

Please try one of our concentrated cleaning solutions, vitamins or supplements, pet care or auto care products or cosmetics from our exclusive branded product line TODAY. I'm sure you will find the basics that you use everyday in your homes are available on our site. Simply transfer your next shopping list to our portal - begin earning CASHBACK - help support your organization - its as easy as that!

I am available to help you navigate the website.
Contact me anytime at (561) 239-7063.
Watch for emails with special sales and promotions.

Happy shopping!
Carri Chicurel

PS I am an MS patient and a member of the MSVN team -

Feel free to ask me about the vitamins and supplements taken daily for optimum health.


Information from The Land Down Under -- Living Well With MS

Maintain good nutrition
We all know the adage, "You are what you eat." Maintaining your health is one of the first steps to managing MS and a big step to maintaining your health is eating well every day. Eating well does not require eating expensive or unusual foods. Quite the opposite! Simple foods from the basic food groups will serve your body and your health. You cam maintain good nutrition and here are 10 ways to get started as well as 5 tips on how nutrition can help with fatigue. For more information click here.

Living with fatigue - relaxation techniques
Relaxation techniques are activities that generate a feeling of complete peace and calm - an active skill that requires development through practice. Relaxation requires both mental and physical rest. It differs from passive activities such as watching television or reading and is not the same as sleeping. Regular relaxation can lead to decreased tension in muscles, lower blood pressure and slower heart rate. Relaxation can also help with fatigue as it promotes good sleeping patterns. For more information on various relaxation techniques click here.

Understanding and improving your posture
Most people have to work at keeping a good posture whether they have MS or not. People with MS often find that keeping a good posture can be more challenging due to factors such as weakness, pain and fatigue. Poor posture can develop gradually, often without even noticing, until it interferes with everyday tasks or causes pain. Simple changes in posture can be beneficial and these can be incorporated into everyday activities. For more information click here.

Exercise and MS
Research shows that exercise can help manage many MS symptoms. Benefits include better cardiovascular fitness, improved strength, better bladder and bowel function, less fatigue and depression, a more positive attitude and increased participation in social activities. With guidelines, a good exercise program can help to develop the maximum potential of muscle, bone and respiration, avoid secondary complications and benefit good health and well-being. For more information on exercise tips and factsheets click here.

MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide 
by signing up by clicking here

Friday, October 2, 2015

Why do doctors recommend TEVA’s Shared Solutions®?


Why do doctors recommend TEVA’s Shared Solutions®?

It is getting the patient started on treatment; it is dealing with insurance issues; it is reviewing with the patient payment issues; co-pays...

Doctors have been compensated by Teva Neuroscience, Inc.

Hear From Doctors Now

Experience the freedom of injection-free weekends,* with 3-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg
*Injections must be at least 48 hours apart.

Why Teva’s COPAXONE®?
  • The #1 prescribed brand for relapsing MS in the US1 †
  • Demonstrated safety and tolerability profile; proven effectiveness
    Based on total number of prescriptions for relapsing forms of MS (IMS National Rx Audit, June 2015).
Why Teva’s Shared Solutions®?
  • A network of support offering a full breadth of personalized services to help patients achieve their relapsing MS management goals
  • Through COPAXONE Co-pay Solutions®, if eligible, your co-pay for 3-times-a-week COPAXONE® 40 mg, could be lowered to $0 per month out of pocket. Terms and conditions apply.

Learn more about Teva’s COPAXONE® and Shared Solutions®


COPAXONE® is indicated for the treatment of patients with relapsing forms of multiple sclerosis.

Important Safety Information 

Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol.

Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.

Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.

A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

The most common side effects in studies of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Please see full 
Prescribing Information.
Reference: 1. IMS Health National Prescription Audit, June 2015. Data proprietary to IMS Health.

Applies only to 3-times-a-week COPAXONE® 40 mg. Certain limits and restrictions apply. Terms and Conditions include: COPAXONE Co-pay Solutions® is open to both new and existing patients who are residents of the US or Puerto Rico and who have commercial prescription insurance coverage for COPAXONE® 40 mg. The offer is not valid for uninsured patients or patients covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of whether a specific prescription is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void where prohibited by law, taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or discontinued at any time without notice. This program is not health insurance.

COPAXONE® and COPAXONE CO-PAY SOLUTIONS® are registered trademarks of Teva Pharmaceutical Industries Ltd.
Shared Solutions® is a registered service mark of Teva Neuroscience, Inc.
© 2015 Teva Neuroscience, Inc. COP-43034

Teva Neuroscience, Inc., COPAXONE® Marketing, 11100 Nall Avenue, Overland Park, KS 66211
Teva Neuroscience  Teva Shared Solutions

This e-mail was sent from, a property of Health Union, LLC, 1 International Plaza, Suite 550 Philadelphia, PA 19113. To unsubscribe, click here.

© 2015 Health Union. All rights reserved. This information is not designed to replace a physician's independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions. does not provide medical advice, diagnosis or treatment. Use of the site is conditional upon your acceptance of our terms of use.

The MS International Federation (MSIF) is fielding a global employment survey to find out how MS affects employment - Please read and respond


If you live with MS or care for someone who does, the MS community needs to hear from you! 

This short survey will help us better understand how MS affects employment around the world. 

Results will be included in a report for World MS Day 2016 and will help us increase awareness and communicate with legislators and employers about how they can help people living with MS to remain in the workforce. 



Experimental cancer drug shows therapeutic promise in mouse models of multiple sclerosis

Information provided to us by Holly S in Florida

Date:         September 30, 2015
Source:      NYU Langone Medical Center

Summary:  An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research.

An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research from NYU Langone Medical Center.

The experimental drug employed by the NYU Langone team of neuroscientists is called GANT61. It blocks the action of a key protein, Gli1, which is involved in so-called sonic hedgehog signaling, a biological pathway closely tied to neural stem cell development and the growth of some cancers, and whose signaling is raised in tissue samples taken from brain lesions in patients with MS.

A report describing the findings is being published in the journal Nature online Sept. 30.
In the study, mice with chemically damaged brain myelin were given daily doses of GANT61 for one month. Results showed that mice that received the drug had 50 percent more myelin at the end of treatment than did untreated mice. Myelin is the nerve-protecting sheath whose degradation is a principal cause of MS.

Moreover, the researchers say, they found that the GANT61-treated mice had an eightfold increase in the number of neural stem cells that migrated to myelin-damaged areas of the brain and eventually developed into myelin-producing oligodendrocytes. Untreated mice did not show this increase.

Clinically, the researchers report, drug-treated mice were able to recover from an initial bout of MS-like paralysis and leg weakness. Untreated mice, however, endured repeated bouts of leg and bladder weakness, symptoms similar to those experienced by people with the disorder.

According to senior study investigator James Salzer, MD, PhD, the experiments, which took six years to complete, are believed to be the first to demonstrate that neural stem cells, and not just early forms of oligodendrocytic cells, can be modified and recruited into myelin repair. Current treatments that target the immune system mostly slow the disease, which primarily targets myelin in the brain and spinal cord, but clinical experts have not yet been able to repair scarred and degraded myelin.

MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide 
by signing up by clicking here

Therapy Focus- The Next Multiple Sclerosis Battleground

Oct. 1, 2015 1:19 PM ET | 

Roche’s (OTCQX:RHHBY) boast on Monday to have in ocrelizumab the first project to show efficacy in a large phase III trial for primary progressive multiple sclerosis is quite a claim, and draws attention to this relatively rare but tricky form of the neurodegenerative disease.

The group might well celebrate: while the relapsing-remitting MS space is crowded, ocrelizumab is one of just a handful of projects in development for the primary progressive form (see table below). However, if Roche has stumbled on a new mechanistic insight this also raises questions that academics and biotechs alike will ask about competing CD20-targeting projects.

Continue learning of this HOPEFUL MS therapy

MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide 
by signing up by clicking here

Ann Romney opens up about life with multiple sclerosis in new book

Click here to read Ann Romney's information

MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide 
by signing up by clicking here

MS One to One Presents - Informative MS educational programs

Trouble viewing? View as a Web page
Do not take AUBAGIO if you have severe liver problems, are pregnant or are of childbearing potential and not using effective birth control, or are taking a medication called leflunomide.
Please click here for full Prescribing Information, including boxed WARNING, and Medication Guide.
The topic is close to you.
Our events are, too.
Just taking some time to listen and ask questions can be a great way to learn something new. So we host a variety of informative events where you can get answers about relapsing forms of multiple sclerosis (MS) and AUBAGIO® (teriflunomide). You'll hear from experts and people living with MS, plus hear about a once-a-day pill for MS. As part of your participation at a live event, a meal may be provided.
Events coming up in your area.
Show me
Have a question about MS or an event?
Talk to an MS One to One® Nurse 24/7 at 1-855-676-6326.
Please scroll down for Important Safety Information.
AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS).
Have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. Your healthcare provider should do blood tests to check your liver within 6 months before you start AUBAGIO and monthly for 6 months after starting AUBAGIO. Tell your healthcare provider right away if you develop any of these symptoms of liver problems: nausea, vomiting, stomach pain, loss of appetite, tiredness, yellowing of your skin or whites of your eyes, or dark urine.
Take a medicine called leflunomide for rheumatoid arthritis.
Are pregnant. AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO. After stopping AUBAGIO, continue to use effective birth control until you have made sure your blood levels of AUBAGIO are lowered. If you become pregnant while taking AUBAGIO or within 2 years after stopping, tell your healthcare provider right away and enroll in the AUBAGIO Pregnancy Registry at 1‑800‑745‑4447, option 2.
Are of childbearing potential and not using effective birth control.
It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed — you should not do both at the same time.
If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO.
AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly.
Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vaccines, vitamins or herbal supplements.
AUBAGIO may cause serious side effects, including: reduced white blood cell count — this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; serious skin problems; breathing problems (new or worsening); and high blood pressure.
The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you.
Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO.
Please click here for full Prescribing Information, including boxed WARNING, and Medication Guide.
You are encouraged to report side effects of prescription drugs to the FDA. Visit or call 1‑800‑FDA‑1088.
Please DO NOT REPLY TO THIS EMAIL. Genzyme will not receive this message if you reply. If you have any questions regarding this email or Genzyme, click here.
To unsubscribe from our mailing list, please click here.
Copyright © 2015 Genzyme Corporation, a Sanofi company. All rights reserved. AUBAGIO and Genzyme are registered trademarks of Genzyme Corporation.
Intended for US residents only.
GZUS.AUBA.15.03.0718 Last Update: March 2015
Last Update: March 2015